NCT06669663View on ClinicalTrials.gov

Hypoxia Driven Metabolic Response in Oesophagogastric Adenocarcinoma

RecruitingOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

September 1, 2024

Primary Completion Date

August 1, 2028

Study Completion Date

August 1, 2028

Conditions
OESOPHAGO-GASTRIC CARCINOMA
Interventions
DRUG

Pimonidazole hydrochloride (Hypoxyprobe™-1)

Participants will receive Pimonidazole (non-CTIMP) prior to their surgery for OG cancer and then undergo intra-operative sampling.

Trial Locations (1)

Unknown

RECRUITING

Imperial College NHS Healthcare Trust, London

All Listed Sponsors
lead

Imperial College London

OTHER